Blood

ISSN	1528-0020
ISSN-L	0006-4971
IUID	eac244673e3d44c09fdd53a3552f6de0
Modified	2020-11-27T13:14:04.637Z
Created	2017-05-09T09:12:07.297Z

Year 2024

PubMed DOI Crossref

Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases.

Thorsson H, Henningsson R, Puente-Moncada N, ..., Lilljebjörn H, Fioretos T

Blood 144 (13) 1399-1411 [2024-09-26; online 2024-07-05]

Clinical Genomics Lund [Service]

PubMed DOI Crossref

Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis.

Chiang SCC, Covill LE, Tesi B, ..., Meeths M, Bryceson YT

Blood 144 (8) 873-887 [2024-08-22; online 2024-07-03]

Clinical Genomics Stockholm [Service]

PubMed DOI Crossref

Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantation.

Dimitriou M, Mortera-Blanco T, Tobiasson M, ..., Woll PS, Jacobsen SEW

Blood 143 (11) 953-966 [2024-03-14; online 2023-12-14]

NGI Short read [Service] NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

Year 2023

PubMed DOI Crossref

The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia.

Hakkarainen M, Kaaja I, Douglas SPM, ..., Kilpivaara O, Wartiovaara-Kautto U

Blood 141 (23) 2853-2866 [2023-06-08; online 2023-03-24]

Clinical Genomics Stockholm [Service]

Year 2022

PubMed DOI Crossref

Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination.

Lisa B, Gao Y, Wullimann D, ..., Hansson L, Osterborg A

Blood - (-) - [2022-09-23; online 2022-09-23]

Autoimmunity and Serology Profiling [Collaborative]

PubMed DOI Crossref

Secondary resistance to idelalisib is characterized by upregulation of IGF1R rather than by MAPK/ERK pathway mutations.

Tausch E, Ljungström V, Agathangelidis A, ..., Rosenquist R, Stilgenbauer S

Blood 139 (22) 3340-3344 [2022-06-02; online 2022-04-05]

Clinical Genomics Uppsala [Service]

PubMed DOI Crossref

Critical role of Lama4 for hematopoiesis regeneration and acute myeloid leukemia progression.

Cai H, Kondo M, Sandhow L, ..., Ekblom M, Qian H

Blood 139 (20) 3040-3057 [2022-05-19; online 2021-12-28]

Bioinformatics Support for Computational Resources [Service]

Year 2021

PubMed DOI Crossref

EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.

Somasundaram R, Jensen CT, Tingvall-Gustafsson J, ..., Ungerbäck J, Sigvardsson M

Blood 137 (22) 3037-3049 [2021-06-03; online 2021-02-24]

Clinical Genomics Linköping [Service]

Year 2020

PubMed DOI Crossref

Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL.

Watanabe A, Miyake K, Nordlund J, ..., Sugita K, Inukai T

Blood 136 (20) 2319-2333 [2020-11-12; online 2020-06-24]

Bioinformatics Support for Computational Resources [Service] NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

PubMed DOI Crossref

Lysine-specific demethylase 1A restricts ex vivo propagation of human HSCs and is a target of UM171.

Subramaniam A, Žemaitis K, Talkhoncheh MS, ..., Zubarev RA, Larsson J

Blood 136 (19) 2151-2161 [2020-11-05; online 2020-06-26]

Bioinformatics Support for Computational Resources [Service] Chemical Proteomics [Collaborative]

DOI Crossref

DNA-Based Methods for Measurable Residual Disease Detection in NPM1-Mutated Acute Myeloid Leukemia; Establishment of Cut-Offs for qPCR, Digital Droplet PCR and Targeted Deep Sequencing

Pettersson L, Johansson Alm S, Almstedt A, ..., Fogelstrand L, Ehinger M

Blood 136 (Supplement 1) 6-6 [2020-11-05; online 2020-11-05]

Clinical Genomics Gothenburg [Collaborative]

PubMed DOI Crossref

13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking.

Yang M, Safavi S, Woodward EL, ..., Nord KH, Paulsson K

Blood 136 (8) 946-956 [2020-08-20; online 2020-05-10]

Clinical Genomics Lund [Service]

PubMed DOI Crossref

AML displays increased CTCF occupancy associated with aberrant gene expression and transcription factor binding.

Mujahed H, Miliara S, Neddermeyer A, ..., Lennartsson A, Lehmann S

Blood 136 (3) 339-352 [2020-07-16; online 2020-04-02]

Bioinformatics Support and Infrastructure [Service] Bioinformatics Support for Computational Resources [Service] Bioinformatics Support, Infrastructure and Training [Service]

PubMed DOI Crossref

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS.

Malcovati L, Stevenson K, Papaemmanuil E, ..., Hellstrom-Lindberg E, Cazzola M

Blood 136 (2) 157-170 [2020-07-09; online 2020-04-30]

Clinical Genomics Uppsala [Service]

Year 2019

PubMed DOI Crossref

A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology.

de Vries PS, Sabater-Lleal M, Huffman JE, ..., O'Donnell CJ, Smith NL

Blood 133 (9) 967-977 [2019-02-28; online 2019-01-14]

NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

Year 2018

PubMed DOI Crossref

Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations

Pellagatti A, Armstrong RN, Steeples V, ..., Smith S, Boultwood J

Blood 132 (12) 1225-1240 [2018-09-20; online 2018-06-21]

Clinical Genomics Uppsala [Service]

PubMed DOI Crossref

Disruption of a GATA1-binding motif upstream of XG/PBDX abolishes Xga expression and resolves the Xg blood group system.

Möller M, Lee YQ, Vidovic K, ..., Storry JR, Olsson ML

Blood 132 (3) 334-338 [2018-07-19; online 2018-05-10]

Structural Proteomics [Collaborative]

PubMed DOI Crossref

Allele-selective RUNX1 binding regulates P1 blood group status by transcriptional control of A4GALT.

Westman JS, Stenfelt L, Vidovic K, ..., Kjellström S, Olsson ML

Blood 131 (14) 1611-1616 [2018-04-05; online 2018-02-08]

Structural Proteomics [Service]

PubMed DOI Crossref

Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow.

Lazarevic V, Orsmark-Pietras C, Lilljebjörn H, ..., Juliusson G, Fioretos T

Blood 131 (5) 577-581 [2018-02-01; online 2017-11-30]

Clinical Genomics Lund [Collaborative]

Year 2017

PubMed DOI Crossref

Gene expression and risk of leukemic transformation in myelodysplasia.

Shiozawa Y, Malcovati L, Gallì A, ..., Cazzola M, Ogawa S

Blood 130 (24) 2642-2653 [2017-12-14; online 2017-11-02]

Clinical Genomics Uppsala [Service]

PubMed DOI Crossref

New oncogenic subtypes in pediatric B-cell precursor acute lymphoblastic leukemia.

Lilljebjörn H, Fioretos T

Blood 130 (12) 1395-1401 [2017-09-21; online 2017-08-04]

Clinical Genomics Lund [Collaborative]

PubMed DOI Crossref

SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells

Mortera-Blanco T, Dimitriou M, Woll PS, ..., Jacobsen SEW, Hellström-Lindberg E

Blood 130 (7) 881-890 [2017-08-17; online 2017-06-20]

Clinical Genomics Uppsala [Service]

PubMed DOI Crossref

Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms.

Tesi B, Davidsson J, Voss M, ..., Cammenga J, Bryceson YT

Blood 129 (16) 2266-2279 [2017-04-20; online 2017-02-15]

Clinical Genomics Stockholm [Service] NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

Year 2016

PubMed DOI Crossref

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.

Mansouri L, Noerenberg D, Young E, ..., Rosenquist R, Damm F

Blood 128 (23) 2666-2670 [2016-12-08; online 2016-09-26]

Clinical Genomics Uppsala [Collaborative]

PubMed DOI Crossref

PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study.

Bruzelius M, Iglesias MJ, Hong MG, ..., Trégouët DA, Odeberg J

Blood 128 (23) e59-e66 [2016-12-08; online 2016-10-14]

Affinity Proteomics Stockholm [Collaborative]

PubMed DOI Crossref

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.

Ljungström V, Cortese D, Young E, ..., Sjöblom T, Rosenquist R

Blood 127 (8) 1007-1016 [2016-02-25; online 2015-12-18]

Clinical Genomics Uppsala [Collaborative] NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

Year 2015

PubMed DOI Crossref

Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF.

Huffman JE, de Vries PS, Morrison AC, ..., O'Donnell CJ, Smith NL

Blood 126 (11) e19-e29 [2015-09-10; online 2015-06-25]

NGI Uppsala (SNP&SEQ Technology Platform) National Genomics Infrastructure

PubMed DOI Crossref

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.

Malcovati L, Karimi M, Papaemmanuil E, ..., Cazzola M, Hellström Lindberg E

Blood 126 (2) 233-241 [2015-07-09; online 2015-05-10]

Clinical Genomics Uppsala NGI Stockholm (Genomics Applications) NGI Stockholm (Genomics Production) National Genomics Infrastructure

PubMed DOI Crossref

Ebf1 heterozygosity results in increased DNA damage in pro-B cells and their synergistic transformation by Pax5 haploinsufficiency.

Prasad MA, Ungerbäck J, Åhsberg J, ..., Hagman J, Sigvardsson M

Blood 125 (26) 4052-4059 [2015-06-25; online 2015-04-02]

Bioinformatics Support and Infrastructure Bioinformatics Support, Infrastructure and Training

Year 2014

PubMed DOI Crossref

Analysis of the DNA methylome and transcriptome in granulopoiesis reveals timed changes and dynamic enhancer methylation.

Rönnerblad M, Andersson R, Olofsson T, ..., Lennartsson A, FANTOM consortium

Blood 123 (17) e79-e89 [2014-04-24; online 2014-03-29]

Bioinformatics and Expression Analysis (BEA) NGI Stockholm (Genomics Applications) NGI Stockholm (Genomics Production) National Genomics Infrastructure

PubMed DOI Crossref

High-throughput transcription profiling identifies putative epigenetic regulators of hematopoiesis.

Prasad P, Rönnerblad M, Arner E, ..., Ekwall K, FANTOM consortium

Blood 123 (17) e46-e57 [2014-04-24; online 2014-03-29]

Bioinformatics and Expression Analysis (BEA)

PubMed DOI Crossref

Robust isolation of malignant plasma cells in multiple myeloma

Frigyesi I, Adolfsson J, Ali M, ..., Hansson M, Nilsson B

Blood 123 (9) 1336-1340 [2014-02-27; online 2014-02-27]

NGI Stockholm (Genomics Applications) NGI Stockholm (Genomics Production) National Genomics Infrastructure

Year 2012

PubMed DOI Crossref

Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation.

Huang J, Sabater-Lleal M, Asselbergs FW, ..., O'Donnell CJ, Hamsten A

Blood 120 (24) 4873-4881 [2012-12-06; online 2012-09-20]

NGI Uppsala (SNP&SEQ Technology Platform) National Genomics Infrastructure

Year 2011

PubMed DOI Crossref

Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks.

Deneberg S, Guardiola P, Lennartsson A, ..., Döhner K, Lehmann S

Blood 118 (20) 5573-5582 [2011-11-17; online 2011-10-01]

NGI Stockholm (Genomics Applications) NGI Stockholm (Genomics Production) National Genomics Infrastructure

Year 2010

PubMed DOI Crossref

DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia.

Milani L, Lundmark A, Kiialainen A, ..., Lönnerholm G, Syvänen AC

Blood 115 (6) 1214-1225 [2010-02-11; online 2009-11-25]

NGI Uppsala (SNP&SEQ Technology Platform) National Genomics Infrastructure

PubMed DOI Crossref

Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia.

Kanduri M, Cahill N, Göransson H, ..., Isaksson A, Rosenquist R

Blood 115 (2) 296-305 [2010-01-14; online 2009-11-10]

Array and Analysis Facility NGI Uppsala (SNP&SEQ Technology Platform) National Genomics Infrastructure